Please use this identifier to cite or link to this item: https://doi.org/10.1258/0956462961917267
DC FieldValue
dc.titleThe potential role of azithromycin in the treatment or prophylaxis of toxoplasmosis
dc.contributor.authorChang, H.R.
dc.date.accessioned2016-11-29T02:51:47Z
dc.date.available2016-11-29T02:51:47Z
dc.date.issued1996
dc.identifier.citationChang, H.R. (1996). The potential role of azithromycin in the treatment or prophylaxis of toxoplasmosis. International Journal of STD and AIDS 7 (SUPPL. 1) : 18-22. ScholarBank@NUS Repository. https://doi.org/10.1258/0956462961917267
dc.identifier.issn09564624
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/132059
dc.description.abstractInfection with Toxoplasma gondii is the most common parasitic infection worldwide with an estimated prevalence of 1-2 billion people. The risk of developing severe toxoplasmosis is higher for immunocompromised individuals and fetuses of mothers who have acquired a prime-infection. The current therapy of choice for toxoplasmosis is the synergistic combination of pyrimethamine, and sulphadiazine. This therapy is highly effective but its use is complicated in immunocompromised individuals due to adverse secondary effects. In addition, since pyrimethamine is potentially teratogenic, its use is not recommended during early pregnancy. Clindamycin, a Lincosaminide, in combination with pyrimethamine has been shown to be an acceptable therapeutic alternative in patients who are unable to tolerate pyrimethamine plus sulphadiazine. In the search for new, effective compounds with less adverse or toxic effects, recent efforts have focused on the new macrolides and the azalides. Here,. the results of the investigations and, in particular, the theoretical considerations for the potential use of azithromycin in the therapy of toxoplasmosis in immunocompromised individuals are reviewed.
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1258/0956462961917267
dc.sourceScopus
dc.subjectAzalides
dc.subjectAzithromycin
dc.subjectMacrolides
dc.subjectToxoplasma gondii
dc.subjectToxoplasmosis
dc.typeConference Paper
dc.contributor.departmentMICROBIOLOGY
dc.description.doi10.1258/0956462961917267
dc.description.sourcetitleInternational Journal of STD and AIDS
dc.description.volume7
dc.description.issueSUPPL. 1
dc.description.page18-22
dc.description.codenINSAE
dc.identifier.isiutA1996TW26100007
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

15
checked on Jul 22, 2021

WEB OF SCIENCETM
Citations

17
checked on Jul 22, 2021

Page view(s)

57
checked on Jul 24, 2021

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.